Publication | Closed Access

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn's Disease: The CHARM Trial

Chronic Inflammatory DiseasesAutoimmune DiseaseImmunologyClinical TrialsGastroenterologyCharm TrialClinical GastroenterologyUlcerative ColitisMedicineClinical Response